Olive Oil and Stroke Risk: A 101,460-Person Meta-Analysis

Why This Study Matters

Observational research has long linked Mediterranean diets to lower cardiovascular risk. But those studies measure entire dietary patterns -- not individual foods. The question of whether olive oil itself contributes to cardiovascular protection, independent of everything else in the diet, is harder to answer.

In 2014, Miguel A. Martinez-Gonzalez and colleagues at the University of Navarra published a meta-analysis in the British Journal of Nutrition that tried to isolate that question. They pooled nine studies -- case-control, cohort, and intervention designs -- covering over 100,000 participants to estimate the effect of olive oil consumption on coronary heart disease (CHD) and stroke risk.

A meta-analysis does not generate new data. It aggregates and statistically combines results from existing studies to increase statistical power and look for patterns that individual studies may be too small to detect. That distinction matters: the strength of a meta-analysis depends entirely on the quality and consistency of the studies it includes.

How It Was Designed

The researchers conducted a systematic literature search across major databases to identify studies that reported olive oil intake and cardiovascular outcomes. The inclusion criteria required that each study provide a quantitative estimate of the association between olive oil consumption and either CHD or stroke (or both), with enough data to calculate a relative risk (RR) or odds ratio.

Nine studies met the criteria. For CHD assessment, the pooled sample included 101,460 participants. For stroke, 38,673 participants.

The statistical approach used random-effects modeling -- a method that accounts for variability between studies rather than assuming they all estimate the same underlying effect. This is the more conservative approach. The researchers also tested for heterogeneity (how much the individual study results differed from each other) and conducted dose-response analyses based on a standardized increment of 25 grams per day of olive oil.

That 25 g/day figure is roughly two tablespoons -- a realistic amount for someone cooking with olive oil as a primary fat.

What They Found

The results differed depending on the outcome measured and the type of study included:

Outcome	Study Type	RR (95% CI)	Participants	Significant?
Stroke	Cohort studies	0.74 (0.60, 0.92)	38,673	Yes
CHD	All study types	0.96 (0.78, 1.18)	101,460	No
Combined CVD	All study types	0.82 (0.70, 0.96)	Combined	Yes

Green indicates a statistically significant protective association. RR values below 1.0 indicate lower risk with higher olive oil intake. All estimates are per 25 g/day increase.

Reading the Results

The headline finding is stroke. For every 25 g/day increase in olive oil consumption, cohort studies showed a 26% lower risk of stroke (RR 0.74). The 95% confidence interval -- 0.60 to 0.92 -- does not cross 1.0, which means the association is statistically significant. There was no significant heterogeneity among the stroke studies, meaning they pointed in the same direction.

When CHD and stroke were combined into a single cardiovascular outcome, the pooled RR was 0.82 (95% CI 0.70, 0.96) -- an 18% lower risk. Again, the confidence interval stays below 1.0.

The dose-response relationship is worth noting. The analysis was standardized to a 25 g/day increment, which means the protective association was observed at a level of intake that is achievable through normal dietary patterns. This was not an extreme or pharmacological dose -- it reflects habitual cooking and food preparation.

What Didn't Change

CHD alone did not reach statistical significance. The pooled RR was 0.96 (95% CI 0.78, 1.18) -- essentially null. The confidence interval comfortably crosses 1.0, so the data cannot distinguish olive oil's effect on CHD from no effect at all.

Importantly, the researchers found significant heterogeneity among the CHD studies. That means the individual study results were inconsistent with each other -- some showed benefit, some did not. When heterogeneity is high, the pooled estimate becomes less reliable because you are averaging over studies that may be measuring different things, in different populations, with different methods.

This does not mean olive oil has no effect on CHD. It means the available evidence at the time was too inconsistent to draw a conclusion. The absence of a significant finding is not the same as evidence of no effect -- it is evidence of insufficient or conflicting data.

Broader Context

This meta-analysis was published in 2014, around the same time the PREDIMED trial was generating its own results. PREDIMED was a large randomized trial that assigned participants to a Mediterranean diet supplemented with extra virgin olive oil, a Mediterranean diet with nuts, or a control diet. It found significant reductions in major cardiovascular events with the olive oil arm -- and its stroke findings aligned with this meta-analysis.

The convergence matters. A meta-analysis of observational data and a randomized trial pointing to the same outcome -- stroke risk reduction with olive oil -- strengthens the overall evidence base, even though neither study type is without limitations.

Why olive oil? The leading hypothesis centers on its polyphenol content. In 2011, the European Food Safety Authority (EFSA) authorized a health claim for olive oil polyphenols -- specifically stating that polyphenols in olive oil contribute to the protection of blood lipids from oxidative stress. That authorization required a minimum of 5 mg of hydroxytyrosol and its derivatives per 20 g of olive oil daily. It remains one of the few food-derived health claims EFSA has approved.

This meta-analysis studied dietary olive oil broadly -- not individual polyphenols in isolation. But the biological plausibility of the stroke finding is consistent with what is known about olive oil polyphenols' effects on oxidative stress, endothelial function, and inflammation.

Related Research

Continue exploring olive oil and polyphenol science:

• Nurses’ Health: Mediterranean Diet & 29% Lower Stroke Risk in 74,886 Women
• Three-City Study: Intensive Olive Oil Use Linked to 41% Lower Stroke Risk
• Olive Oil and Brain Health: 66% Lower Cognitive Impairment Risk in PREDIMED Trial

Source: View the original study on PubMed

Olivea's Dosage

This study examined dietary olive oil intake, not supplementation. The observed benefit was at 25 g/day -- roughly two tablespoons of olive oil. Each Olivea capsule delivers the polyphenol content of olive oil in concentrated form. Our most recent third-party certificate of analysis confirmed 23.5 mg of hydroxytyrosol per capsule.

We share this research for transparency. This is an independent study -- we did not fund it, design it, or conduct it.

Editorial Information

Research note. This article summarizes third-party research published in a peer-reviewed journal. Olivea did not conduct or fund the study. Findings reflect the cited paper only and do not establish efficacy of Olivea products.

.